Raymond James Financial »

Sagimet Biosciences Inc-a shares owned by Raymond James Financial

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 278k 6.86
2025-06-30 $2.0M 265k 7.62
2025-03-31 $1.1M 346k 3.26

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Sagimet Biosciences Inc-a

Woodline Partners
Blue Owl Capital Holdings
Vanguard Group
Baker Bros. Advisors
Millennium Management
Hillhouse Capital Advisors
Siren
D. E. Shaw & Co
BlackRock
Schonfeld Strategic Advisors
Affinity Asset Advisors
Readystate Asset Management
UBS Group
Bridgeway Capital Management
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a